| Stratified medicine for mental disorders G Schumann, EB Binder, A Holte, ER de Kloet, KJ Oedegaard, ... European Neuropsychopharmacology 24 (1), 5-50, 2014 | 269 | 2014 |
| Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study RA Kroken, E Johnsen, T Ruud, T Wentzel-Larsen, HA Jørgensen BMC psychiatry 9, 1-9, 2009 | 157 | 2009 |
| Suicidality in schizophrenia spectrum disorders: the relationship to hallucinations and persecutory delusions E Kjelby, I Sinkeviciute, R Gjestad, RA Kroken, EM Løberg, HA Jørgensen, ... European psychiatry 30 (7), 830-836, 2015 | 114 | 2015 |
| Effectiveness of second generation antipsychotics: a systematic review of randomized trials E Johnsen, HA Jørgensen BMC psychiatry 8, 1-14, 2008 | 96 | 2008 |
| Cannabis use is associated with 3 years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N= 1119) S Helle, PA Ringen, I Melle, TK Larsen, R Gjestad, E Johnsen, ... Schizophrenia research 170 (1), 217-221, 2016 | 93 | 2016 |
| Constructing the immune signature of schizophrenia for clinical use and research; an integrative review translating descriptives into diagnostics RA Kroken, IE Sommer, VM Steen, I Dieset, E Johnsen Frontiers in psychiatry 9, 409313, 2019 | 84 | 2019 |
| The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis E Johnsen, F Fathian, RA Kroken, VM Steen, HA Jørgensen, R Gjestad, ... BMC psychiatry 16, 1-11, 2016 | 78 | 2016 |
| Auditory verbal hallucinations in schizophrenia as aberrant lateralized speech perception: evidence from dichotic listening K Hugdahl, EM Løberg, LE Falkenberg, E Johnsen, K Kompus, ... Schizophrenia research 140 (1-3), 59-64, 2012 | 77 | 2012 |
| Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone E Johnsen, RA Kroken, T Wentzel-Larsen, HA Jørgensen BMC psychiatry 10, 1-13, 2010 | 74 | 2010 |
| Glutamate as a mediating transmitter for auditory hallucinations in schizophrenia: A 1H MRS study K Hugdahl, AR Craven, M Nygård, EM Løberg, JØ Berle, E Johnsen, ... Schizophrenia research 161 (2-3), 252-260, 2015 | 70 | 2015 |
| Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis I Sinkeviciute, M Begemann, M Prikken, B Oranje, E Johnsen, WU Lei, ... NPJ schizophrenia 4 (1), 22, 2018 | 67 | 2018 |
| Antipsychotic-induced hyperprolactinemia: a cross-sectional survey E Johnsen, RA Kroken, M Abaza, H Olberg, HA Jørgensen Journal of clinical psychopharmacology 28 (6), 686-690, 2008 | 65 | 2008 |
| Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia LE Falkenberg, R Westerhausen, AR Craven, E Johnsen, RA Kroken, ... NeuroImage: Clinical 4, 576-584, 2014 | 64 | 2014 |
| The role of the primary auditory cortex in the neural mechanism of auditory verbal hallucinations K Kompus, LE Falkenberg, JJ Bless, E Johnsen, RA Kroken, B Kråkvik, ... Frontiers in Human Neuroscience 7, 144, 2013 | 59 | 2013 |
| A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation RA Kroken, EM Løberg, T Drønen, R Grüner, K Hugdahl, K Kompus, ... Frontiers in psychiatry 5, 11, 2014 | 57 | 2014 |
| Failure of attention focus and cognitive control in schizophrenia patients with auditory verbal hallucinations: evidence from dichotic listening K Hugdahl, M Nygård, LE Falkenberg, K Kompus, R Westerhausen, ... Schizophrenia Research 147 (2-3), 301-309, 2013 | 57 | 2013 |
| Trends in utilization and dosing of antipsychotic drugs in Scandinavia: comparison of 2006 and 2016 M Højlund, A Pottegård, E Johnsen, RA Kroken, J Reutfors, ... British journal of clinical pharmacology 85 (7), 1598-1606, 2019 | 51 | 2019 |
| Patients with schizophrenia fail to up-regulate task-positive and down-regulate task-negative brain networks: an fMRI study using an ICA analysis approach M Nygård, T Eichele, EM Løberg, HA Jørgensen, E Johnsen, RA Kroken, ... Frontiers in Human Neuroscience 6, 149, 2012 | 48 | 2012 |
| Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial E Kjelby, HA Jørgensen, RA Kroken, EM Løberg, E Johnsen BMC psychiatry 11, 1-10, 2011 | 48 | 2011 |
| Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial E Johnsen, RA Kroken, EM Løberg, M Rettenbacher, I Joa, TK Larsen, ... The Lancet Psychiatry 7 (11), 945-954, 2020 | 46 | 2020 |
